Ampio Pharmaceuticals Inc. | Ownership
Companies that own Ampio Pharmaceuticals Inc.
Heights Capital Management, Inc.
6,500,000
6.1%
3,622,114
0.12%
08/09/2018
BlackRock Fund Advisors
4,718,831
4.43%
3,486,844
0%
06/30/2018
The Vanguard Group, Inc.
3,246,764
3.05%
349,874
0%
06/30/2018
Knoll Capital Management LP
2,595,484
2.44%
0
1.42%
06/30/2018
ACT Capital Management LLLP
1,210,785
1.13%
-3,464,715
6.6%
08/08/2018
Northern Trust Investments, Inc.
850,903
0.8%
710,911
0%
06/30/2018
SSgA Funds Management, Inc.
841,163
0.79%
790,248
0%
06/30/2018
Geode Capital Management LLC
692,173
0.65%
204,763
0%
06/30/2018
DWS Investment GmbH
401,050
0.38%
175,429
0%
06/30/2018
Valeo Financial Advisors LLC
330,000
0.31%
330,000
0.03%
06/30/2018
| Address |
373 Inverness Parkway
Englewood Colorado 80112
United States
|
|
Employees
|
- |
| Website |
http://www.ampiopharma.com |
| Updated |
07/08/2019 |
| Ampio Pharmaceuticals, Inc. is a biopharmaceutical company, that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Greenwood Village, CO. |
